HANZEMA

Approval Id: faa1058c1d1f819b
Drug Approval Canada Name: HANZEMA
Product Name: HANZEMA
Status: Marketed
Status Date: 2021-06-09
Original Market Date: 2021-06-09
Din: 02477440
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 84:92.00
Atc Original: D11AH04 ALITRETINOIN
Atc Name: d 11 ah 04
Aig Number: 0137581003
Company Name: DR. REDDY'S LABORATORIES, INC.
Company Address: SUITE 4000 4TH FLOOR, 600 College Road East, Princeton, New Jersey, United States, 08540
Company Detail Path: /organization/dr-reddys-laboratories-inc

ALITRETINOIN

30 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

faa1058c1d1f819b

Type

Standard